Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.64 |
| ▸ | NPC1L1 | Q9UHC9 | 3/20 | 0.58 |
| ▸ | CDC25A | P30304 | 3/20 | 0.56 |
| ▸ | CDC25B | P30305 | 1/20 | 0.56 |
| ▸ | POLA1 | P09884 | 1/20 | 0.56 |
| ▸ | OSBP | P22059 | 1/20 | 0.53 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | USP2 | O75604 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | SRD5A1 | P18405 | 3/20 | 0.53 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.53 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.53 |
| ▸ | EFNA1 | P20827 | 1/20 | 0.53 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL133952 | 1.00 | CYP2D6 (0.65) | CYP2D6CYP2C19INPP5DNPC1L1CDC25A | |
| SCHEMBL9224303 | 1.00 | CYP2D6 (0.65) | CYP2D6CYP2C19INPP5DNPC1L1CDC25A | |
| SCHEMBL3447573 | 1.00 | CYP2D6 (0.65) | CYP2D6CYP2C19INPP5DNPC1L1CDC25A | |
| Water SCHEMBL4949873 | 0.99 | CYP2D6 (0.64) | CYP2D6CYP2C19INPP5DNPC1L1CDC25A | |
| Methoxymethane SCHEMBL4786442 | 0.97 | CYP2D6 (0.61) | CYP2D6CYP2C19INPP5DNPC1L1CDC25A | |
| SCHEMBL4737679 | 0.94 | CYP2D6 (0.58) | CYP2D6CYP2C19INPP5DNPC1L1CDC25A | |
| Ether SCHEMBL4736865 | 0.94 | CYP2D6 (0.58) | CYP2D6CYP2C19INPP5DNPC1L1CDC25A | |
| Epicoprosterol SCHEMBL6519923 | 0.93 | CYP2C19 (0.66) | CYP2D6CYP2C19INPP5DCDC25APOLA1 | |
| SCHEMBL4739574 | 0.93 | CYP2D6 (0.57) | CYP2D6CYP2C19INPP5DNPC1L1CDC25A | |
| SCHEMBL734988 | 0.91 | CYP2D6 (0.53) | CYP2D6CYP2C19INPP5DNPC1L1CDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3110 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139254-A1 | INTERFERING RNA FOR INHIBITING TOP1 GENE EXPRESSION AND USE THEREOF | JENKEM TECH CO LTD BEIJING (CN) | 2026-05-21 | — | — | US | claimed |
| EP-4743437-A1 | DIESTER LIPIDS, LIPID NANOPARTICLE CONTAINING DIESTER LIPIDS, AND FORMULATIONS THEREOF | Providence Therapeutics Holdings Inc. (CA) | 2026-05-20 | — | — | EP | claimed |
| EP-4737436-A1 | CATIONIC LIPID CONTAINING TWO TERTIARY AMINE GROUPS, AND USE THEREOF | Xiamen Sinopeg Biotech Co., Ltd (CN) | 2026-05-06 | — | — | EP | claimed |
| EP-4731258-A1 | LIPID NANOPARTICLES CONTAINING DISULFIDE LIPIDS AND FORMULATIONS THEREOF | Providence Therapeutics Holdings Inc. (CA) | 2026-04-29 | — | — | EP | claimed |
| EP-4321504-B1 | PEGYLATED LIPID AND LIPOSOME MODIFIED THEREBY, AND PHARMACEUTICAL COMPOSITION COMPRISING LIPOSOME AND PREPARATION AND USE THEREOF | XIAMEN SINOPEG BIOTECH CO LTD (CN) | 2026-02-18 | — | — | EP | claimed |
| US-20250345453-A1 | CHEMOTHERAPEUTIC MICELLULAR NANOPARTICLES | PEPTINOVO BIOPHARMA INC (US) | 2025-11-13 | — | — | US | claimed |
| US-20250313844-A1 | INTERFERING RNA FOR INHIBITING PCSK9 GENE EXPRESSION AND USE THEREOF | JENKEM TECHNOLOGY CO., LTD. (BEIJING) (CN) | 2025-10-09 | — | — | US | claimed |
| US-20250313860-A1 | EXPRESSION OF EXOGENOUS PROTEINS IN DONOR PLATELETS TREATED WITH LIPID NANOPARTICLES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2025-10-09 | — | — | US | claimed |
| EP-4628497-A1 | STEROID-CATIONIC LIPID COMPOUND AND USE THEREOF | Jenkem Technology Co., Ltd. (Liaoning) (CN) | 2025-10-08 | — | — | EP | claimed |
| EP-4628496-A1 | STEROID-CATIONIC LIPID COMPOUND AND USE THEREOF | Jenkem Technology Co., Ltd. (Liaoning) (CN) | 2025-10-08 | — | — | EP | claimed |
| US-5436004-A | Capsules with carriers and cholesterol reductase as anticholesterol agents | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1995-07-25 | — | — | US | claimed |
| EP-0251905-B1 | Esters of alginic acid | FIDIA SPA (IT) | 1994-11-02 | — | — | EP | claimed |
| EP-0609968-A2 | Compositions comprising partial esters of alginic acid | FIDIA S.p.A. (IT) | 1994-08-10 | — | — | EP | claimed |
| WO-1993004672-A1 | METHOD FOR ENHANCING THE IMMUNE SYSTEM IN A HOST EMPLOYING LIPOSOME-ENCAPSULATED POLYPEPTIDES | PITMAN-MOORE, INC. (US) | 1993-03-18 | — | — | WO | claimed |
| EP-0246540-B1 | IMPLANT PREPARATIONS FOR DELIVERY OF BIOACTIVE MACROMOLECULES | Wang, Paul Y. (CA) | 1992-08-05 | — | — | EP | claimed |
| US-5110595-A | Compression of mixture of polypeptide and lipid powder | WANG PAUL Y (CA) | 1992-05-05 | — | — | US | claimed |
| US-4921710-A | Method of converting cholesterol in food to coprostanol | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1990-05-01 | — | — | US | claimed |
| CN-87104499-A | Novel alginic acid esters | — | 1988-04-06 | — | — | CN | claimed |
| EP-0251905-A2 | Esters of alginic acid | FIDIA S.p.A. (IT) | 1988-01-07 | — | — | EP | claimed |
| EP-0246540-A2 | Implant preparations for delivery of bioactive macromolecules | Wang, Paul Y. (CA) | 1987-11-25 | — | — | EP | claimed |